Provided by Tiger Fintech (Singapore) Pte. Ltd.

Candel Therapeutics, Inc.

4.71
+0.19504.32%
Volume:224.43K
Turnover:1.06M
Market Cap:222.24M
PE:-2.70
High:4.85
Open:4.60
Low:4.60
Close:4.51
Loading ...

Candel Therapeutics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
27 Feb

Candel Therapeutics Price Target Maintained With a $19.00/Share by HC Wainwright & Co.

Dow Jones
·
26 Feb

Analysts Are Bullish on Top Healthcare Stocks: Candel Therapeutics (CADL), Day One Biopharmaceuticals (DAWN)

TIPRANKS
·
26 Feb

Promising Potential of Candel Therapeutics’ CAN-2409: Analyst Recommends ‘Buy’ Based on Compelling Phase 2 Trial Results and Future Outlook

TIPRANKS
·
26 Feb

Candel Therapeutics Shares Fall After Final Pancreatic Cancer Survival Data

MT Newswires Live
·
26 Feb

Candel Therapeutics Shares Reverse Course From Premarket Gains; Last Down 4.7%

THOMSON REUTERS
·
25 Feb

Candel Therapeutics Shares up 4% Premarket After Positive Results From Early Trial of Cancer Drug

THOMSON REUTERS
·
25 Feb

Candel Therapeutics Inc - Can-2409 Associated With Favorable Safety/Tolerability Profile

THOMSON REUTERS
·
25 Feb

Candel Therapeutics Inc - Can-2409 Safety Profile Generally Favorable in Phase 2 Trial

THOMSON REUTERS
·
25 Feb

Candel Therapeutics Announces Positive Final Survival Data From Randomized Controlled Phase 2 Clinical Trial of Can-2409 in Non-Metastatic Pancreatic Cancer

THOMSON REUTERS
·
25 Feb

Candel Therapeutics Announces Positive Final Survival Data from Randomized Controlled Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer

GlobeNewswire
·
25 Feb

Citigroup Initiates Candel Therapeutics at Buy With $25 Price Target

MT Newswires Live
·
20 Feb

Candel Therapeutics Initiated at Buy by Citigroup

Dow Jones
·
20 Feb

Cantor Fitzgerald Initiates Candel Therapeutics at Buy With $20 Price Target

MT Newswires Live
·
19 Feb

Candel Therapeutics Inc : Canaccord Genuity Initiates Coverage With Buy Rating; Target Price $20

THOMSON REUTERS
·
19 Feb

Candel Therapeutics Initiated at Buy by Canaccord Genuity

Dow Jones
·
19 Feb

Candel Therapeutics initiated with a Buy at Canaccord

TIPRANKS
·
19 Feb

BofA Securities Initiates Candel Therapeutics at Buy With $15 Price Target

MT Newswires Live
·
07 Feb

Largest borrow rate increases among liquid names

TIPRANKS
·
28 Jan

Insider Stock Buying Of Candel Therapeutics Delivers Return On US$3.00m Investment

Simply Wall St.
·
18 Jan